Novavax (NVAX) Retained Earnings (2016 - 2025)
Novavax (NVAX) has 16 years of Retained Earnings data on record, last reported at -$4.6 billion in Q4 2025.
- For Q4 2025, Retained Earnings fell 20149.78% year-over-year to -$4.6 billion; the TTM value through Dec 2025 reached -$4.6 billion, down 20149.78%, while the annual FY2025 figure was -$4.6 billion, 20149.78% down from the prior year.
- Retained Earnings reached -$4.6 billion in Q4 2025 per NVAX's latest filing, roughly flat from -$4.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $4.2 million in Q2 2021 and bottomed at -$5.0 billion in Q1 2024.
- Average Retained Earnings over 5 years is -$2.6 billion, with a median of -$3.8 billion recorded in 2021.
- Peak YoY movement for Retained Earnings: plummeted 956354.34% in 2022, then surged 142.68% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$3.6 billion in 2021, then soared by 99.82% to -$6.4 million in 2022, then surged by 142.68% to $2.7 million in 2023, then plummeted by 928.77% to -$22.6 million in 2024, then plummeted by 20149.78% to -$4.6 billion in 2025.
- Per Business Quant database, its latest 3 readings for Retained Earnings were -$4.6 billion in Q4 2025, -$4.6 billion in Q3 2025, and -$4.4 billion in Q2 2025.